Welcome to Bone Marrow Transplantation!

Bone Marrow Transplantation publishes high quality, peer reviewed original research and reviews that address all aspects of basic biology and clinical use of haemopoietic cell transplantation. The journal also covers all aspects of the research and treatment of transplant-related complications and consequences including quality of life and psychological issues. Basic research studies on topics of relevance are also covered. The broad scope of the journal encompasses topics such as stem cell biology, transplantation immunology (including animal models), translational research, biomarkers, cellular therapy, and clinical results of specific protocols.

Impact Factor: 3.636*

Submit to Bone Marrow Transplantation.

BMT is celebrating its 30th anniversary - Read our special anniversary collection featuring the top 10 articles of all time

Free online issue

Volume 52, No 5
May 2017

ISSN: 0268-3369
EISSN: 1476-5365

2015 Impact Factor 3.636*
21/70 Hematology
54/150 Immunology
71/213 Oncology
10/25 Transplantation

H Lazarus, USA
M Mohty, France

*2015 Journal Citation Reports® Science Edition (Thomson Reuters, 2016)

Not to be missed

See the Editors pick of recent articles

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants Open
J R Passweg, H Baldomero, P Bader et al.
In a report based on data obtained from a 2013 survey in Europe, the alternative donor graft source has changed with a marked increase in haploidentical donors, accompanied by a slight decrease in umbilical cord blood units for recipients.

Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD
B Frey Tirri, P Häusermann, H Bertz et al
These investigators highlight the need and provide a comprehensive review of the recommendations for gynecologic health in women who develop female genital chronic graft-versus-host disease, a here-to-fore less-well appreciated complication of allogeneic hematopoietic cell transplantation.

5-Azacytidine and DLI can induce long-term remissions in AML patients relapsed after allograft
J Steinmann, H Bertz, R Wäsch et al
The use of low-dose 5-azacytidine and donor lymphocyte infusion can induce long-term remissions in AML patients who have relapsed after undergoing an allogeneic hematopoietic cell transplant.

Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission
F V Michelis, E G Atenafu, V Gupta et al
While secondary AML patient outcomes using conventional therapy are much worse than de novo AML, the use of allogenic HCT in this group provides results comparable to de novo AML patients who also undergo allograft.

Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group—an observational analysis by the Acute Leukemia Working Party of the EBMT
J R Passweg, M Labopin, J Cornelissen et al
Using data from the EBMT observational database, myeloablative conditioning in middle-aged AML patients undergoing allogeneic transplant in first complete remission provided no patient outcome advantage compared to lesser intensity approaches irrespective of the disease risk group.

Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor
V Bachanova, L J Burns, T Wang et al
Even in lymphoma patients who have relapsed after an autologous transplant and who do not have an adequately matched HLA-identical sibling donor, survival has markedly been improved by greater utilization of hematopoietic grafts obtained from alternative donors.


Celebrating 30 years of publication

BMT published its first issue in 1986 following the decision from Founding Editor, John Goldman, that there was a need for a journal focused on bone marrow transplantation.

In this special web focus we feature some of the key articles published during the last 30 years, as well as a personal look back over the history of BMT from original editor Robert Peter Gale. Read the anniversary issue for FREE today

Meet the Editors at ASH 2016

Come and meet the Editors-in-Chief of BMT on Sunday 4th December 2016 at exhibition booth #4402 at ASH 2016 in San Diego.

The Editors will be available from 12pm-2pm to answer your questions and provide advice on how to get your research published in BMT.

Post a video summary of your research

Bone Marrow Transplantation is pleased to announce that authors can now upload video presentations to accompany their article when published. Presentations should provide a short, succinct summary of the research and be uploaded as Supplementary Material. Whilst enhancing reader experience, video summaries also provide an excellent tool for promotion to help increase visibility and reach. Please refer to the journal's Instructions for Authors for technical specifications.

How to get Published Session at EBMT 2016

Tuesday 05 April 2016, 13:45 - 14:45pm, Room B1, Convention & Exhibition Centre of Feria Valencia

Hosted by Mohamad Mohty (Editor-in-Chief, BMT) and Junia Melo, Imperial College, London

This session will provide invaluable information for both established and prospective authors including:

  • How to pick an appropriate outlet for publication
  • How to draft and finalize a manuscript for publication
  • Adhering to journal policies
  • How the peer review process works
  • Key features sought by Editors and how to interpret their response
  • Maximizing dissemination of your paper after publication

The session will allow ample time for attendees to ask questions

Thank you to our reviewers
We would like to thank all those who took the time to review for Bone Marrow Transplantation in 2015. The journal could not exist without the knowledge and critical evaluation that our reviewers provide. Your generosity is much appreciated, and we hope your association with the journal continues in future. Please click here for the full list of reviewers.

Open Access Publication
Authors of research articles can opt to pay an article processing charge (APC) for their accepted articles to be open access online immediately upon publication. Open access articles are published under Creative Commons licenses, which allow authors to retain copyright to their work while making it open to readers.
Visit our Open Research Site for detailed information about publishing open access.

More free articles
Bone Marrow Transplantation articles are now free online 12 months after print publication. Browse through our past papers in the archive

Extra navigation

24 May 2017